Archives

Civil Society Position on European Commission Proposal for the Introduction of an SPC Manufacturing Waiver

Joint Statement | 6 November, 2018 | Download PDF As civil society organisations working on access to medicines and public health, we wish to contribute to the ongoing discussions on…

6 November 2018

Statement to WHO on Roadmap Report on Access to Medicines & Vaccines

Intervention | 10 September, 2018 | Download PDF Stichting Health Action International (HAI) welcomes the opportunity to contribute to the discussions on the World Health Organization’s (WHO) Roadmap for Access…

10 September 2018

Joint Letter to WHO Director-General: WHO’s Roadmap on Access to Medicines and Vaccines 2019-2023

Joint Letter | 7 August, 2018 | Download PDF Health Action International joined Knowledge Ecology International (KEI), and other civil society organisations, in writing to the Director-General of the World…

Statement to WHO Executive Board 142: Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property

Intervention | 24 January, 2018 | Download PDF Health Action International welcomes the Director General’s report on the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual…

24 January 2018

Statement to WHO Executive Board 142: Addressing the Global Shortage of, and Access to, Medicines and Vaccines

Intervention | 24 January, 2018 | Download PDF Health Action International appreciates the opportunity to address the Executive Board on a topic that remains both our passion and core business:…

24 January 2018

Statement to WHO Executive Board 142: Addressing the Burden of Snakebite Envenoming

Intervention | 24 January, 2018 | Download PDF Health Action International (HAI) appreciates the opportunity to address the Executive Board on a public health issue of immense gravity. We know…

24 January 2018

Recommendations to Strengthen WHO EURO Member State Collaboration on Improving Access to Medicines

13 September, 2017 | Joint Intervention* | Download PDF Oral Contribution: Provisional agenda item 5(d) Strengthening Member State collaboration on improving access to medicines in the WHO European Region EUR/RC67/11…

13 September 2017

WHA69 Intervention on Global Medicine Shortages and the Safety and Accessibility of Children’s Medication

Jordan Jarvis of the Health Action International delegation submitted the following intervention at the 69th World Health Assembly in Geneva (A69/1): Agenda Item: 16.4 Addressing the global shortages of medicines, and the…

HAI and KEI Submit WHA69 Intervention on Follow-up CEWG Report

Health Action International, in collaboration with Knowledge Ecology International, submitted the following intervention at the 69th World Health Assembly in Geneva (A69/1): Agenda Item: 16.2 Follow-up to the report of the Consultative Expert…

HAI Submits Intervention on Establishing a Global Development and Stewardship Framework for Antimicrobial Medicines and Other Interventions at WHA69

Dr Gemma Buckland Merrett, Senior Research Manager with Health Action International submitted the following intervention at the 69th World Health Assembly in Geneva (A69/1). Agenda Item: 14.4 Global action plan on antimicrobial…

HAI Intervention on Ensuring Access to Antimicrobial Drugs, Diagnostics and Vaccines

5 April, 2016 World Health Organization–Non-governmental Organisations Antimicrobial Resistance Dialogue GEMMA BUCKLAND-MERRETT, Senior Research Manager Access to Antibiotics In many countries, access to antimicrobial treatment is now viewed as…

HAI Intervention at the United Nations High-Level Panel on Access to Medicines

London (10 March 2016)—Health Action International is an independent global network of over 2,000 pharmaceutical policy experts. Together, we have advocated for improved access to quality-assured essential medicines—and their rational…